Title : Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro.

Pub. Date : 2014 Mar

PMID : 24487968






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 C817 (0.5 or 1 mumol/L) dose-dependently inhibited the phosphorylation of Bcr-Abl and downstream proteins STAT-5 and CrkL in imatinib-resistant K562/G01 cells. Imatinib Mesylate signal transducer and activator of transcription 5A Homo sapiens